12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CAPIOX RX OXYGENATOR WITH OR WITHOUT RESERVOIR

FDA 510(k)
FDA Class 2 ·Cardiovascular

WALL MEDICAL, INC.

FDA registration
WALL MEDICAL, INC.·2 products·🇺🇸 United States

PENTAFERTE SINGLE USE SYRINGES, MODEL SIZE=VARIOUS SIZES

FDA 510(k)
FDA Class 2 ·General Hospital

PROFILE 1320 LASER SYSTEM

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

CONSULT HCG TEST

FDA Adverse Event
Malfunction ·ALERE SAN DIEGO, INC.·Product code JHI·March 4, 2025

OT VERIO IQ METER

FDA Adverse Event
Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·April 16, 2013

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·April 12, 2011

RESOLUTION CLIP DEVICE

FDA Adverse Event
Malfunction ·BOSTON SCIENTIFIC CORPORATION·Product code MND·June 18, 2008

CONSULT HCG URINE CASSETTE 5001 25T

FDA Adverse Event
Malfunction ·ALERE SAN DIEGO, INC.·Product code JHI·September 9, 2019

BD PHOENIX¿ NMIC/ID-307

FDA Adverse Event
Malfunction ·BECTON DICKINSON & CO. (SPARKS)·Product code LON·October 29, 2025

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015